Literature DB >> 22803831

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

Laura Tonnetti1, Aaron M Thorp, Heather L Reddy, Shawn D Keil, Raymond P Goodrich, David A Leiby.   

Abstract

BACKGROUND: Babesia microti is the parasite most frequently transmitted by blood transfusion in the United States. Previous work demonstrated the efficacy of riboflavin (RB) and ultraviolet (UV) light to inactivate B.microti in apheresis plasma and platelet units. In this study we investigated the effectiveness of RB and UV light to reduce the levels of B.microti in whole blood (WB). STUDY DESIGN AND METHODS: WB units were spiked with B. microti-infected hamster blood. Spearman-Karber methods were used to calculate infectivity of each sample in terms of hamster infectious dose 50% (HID50 ) value. After RB addition, the units were illuminated with 80 J/mLRBC UV light. Two samples were collected: one before illumination and one after illumination. The samples were serially diluted and dilutions injected into a group of five naive hamsters. Four weeks postinoculation (PI), blood was collected from the animals and evaluated by microscopic observation.
RESULTS: One pilot study showed a good dose response in the animals and demonstrated that sample infectivity could be calculated in terms of an HID50 . Three additional replicates were performed in the same manner as the pilot study, but with fewer dilutions. Infectivity values were consistent between the experiments and were used to calculate log reduction. The posttreatment reduction of B. microti for all the experiments was more than 5 log.
CONCLUSIONS: The data collected indicate that use of RB and UV is able to decrease the parasite load in WB units thus reducing the risk of transfusion-transmitted B. microti from blood components containing B. microti-infected RBCs.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803831     DOI: 10.1111/j.1537-2995.2012.03791.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment.

Authors:  Rosalynn Louise Ord; Cheryl A Lobo
Journal:  Curr Clin Microbiol Rep       Date:  2015-09-28

Review 2.  Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

Authors:  Susan Yonemura; Suzann Doane; Shawn Keil; Raymond Goodrich; Heather Pidcoke; Marcia Cardoso
Journal:  Blood Transfus       Date:  2017-05-11       Impact factor: 3.443

3.  Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood.

Authors:  Rachael P Jackman; Marcus O Muench; Heather Inglis; John W Heitman; Susanne Marschner; Raymond P Goodrich; Philip J Norris
Journal:  Transfusion       Date:  2016-11-18       Impact factor: 3.157

4.  A longitudinal study of Babesia microti infection in seropositive blood donors.

Authors:  David A Leiby; Stephanie T Johnson; Kimberly Y Won; Eva K Nace; Susan B Slemenda; Norman J Pieniazek; Ritchard G Cable; Barbara L Herwaldt
Journal:  Transfusion       Date:  2014-03-28       Impact factor: 3.157

Review 5.  Transfusion-transmitted babesiosis: is it time to screen the blood supply?

Authors:  Andrew E Levin; Peter J Krause
Journal:  Curr Opin Hematol       Date:  2016-11       Impact factor: 3.284

6.  Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of Storage.

Authors:  Lina Y Dimberg; Suzann K Doane; Susan Yonemura; Heather L Reddy; Nick Hovenga; E Jane Gosney; Melissa Tran; Shilo Wilkinson; Raymond P Goodrich; Susanne Marschner
Journal:  Transfus Med Hemother       Date:  2019-02-22       Impact factor: 3.747

7.  Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage.

Authors:  Shirley Owusu-Ofori; Joseph Kusi; Alex Owusu-Ofori; Graham Freimanis; Christine Olver; Caitlyn R Martinez; Shilo Wilkinson; Janna M Mundt; Shawn D Keil; Raymond P Goodrich; Jean-Pierre Allain
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

8.  Babesia: an emerging infectious threat in transfusion medicine.

Authors:  Cheryl A Lobo; Jeny R Cursino-Santos; Andy Alhassan; Marilis Rodrigues
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

9.  Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).

Authors:  Chintamani Atreya; Simone Glynn; Michael Busch; Steve Kleinman; Edward Snyder; Sara Rutter; James AuBuchon; Willy Flegel; David Reeve; Dana Devine; Claudia Cohn; Brian Custer; Raymond Goodrich; Richard J Benjamin; Anna Razatos; Jose Cancelas; Stephen Wagner; Michelle Maclean; Monique Gelderman; Andrew Cap; Paul Ness
Journal:  Transfusion       Date:  2019-05-29       Impact factor: 3.157

10.  Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.

Authors:  Geraldine M Walsh; Andrew W Shih; Ziad Solh; Mia Golder; Peter Schubert; Margaret Fearon; William P Sheffield
Journal:  Transfus Med Rev       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.